Publications by authors named "Norbert Hittel"

Claim this Profile
I
Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials.
Andrew R DiNardo, Wilbert Sabiiti, Stephen H Gillespie, Sophia B Georghiou, Norbert Heinrich, Norbert Hittel

Front Antibiot· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles.
Stephen H Gillespie, Andrew R DiNardo, Sophia B Georghiou, Wilber Sabiiti, Mikashmi Kohli, Norbert Hittel

Lancet Microbe· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-Care COVID-19 Antigen Testing in Exposed German Healthcare Workers-A Cost Model.
Roland Diel, Norbert Hittel, Albert Nienhaus

Int J Environ Res Public Health· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update.
Sambuddha Ghosh, Lusine Breitscheidel, Natasa Lazarevic, Alexandra Martin, Jeffrey Hafkin, Norbert Hittel

Eur Respir J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of delamanid-containing regimens in multidrug-resistant and extensively drug-resistant tuberculosis patients in a specialised treatment centre in Berlin, Germany.
Brit Häcker, Nicolas Schönfeld, David Krieger, Ralf Otto-Knapp, Norbert Hittel

Eur Respir J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Florian von Groote-Bidlingmaier, Ramonde Patientia, Epifanio Sanchez, Vincent Balanag, Eduardo Ticona, Norbert Hittel

Lancet Respir Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis.
Jeffrey Hafkin, Norbert Hittel, Alexandra Martin, Rajesh Gupta

Eur Respir J· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
Liga Kuksa, Linda Barkane, Norbert Hittel, Rajesh Gupta

Eur Respir J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use.
Jeffrey Hafkin, Norbert Hittel, Alexandra Martin, Rajesh Gupta

Eur Respir J· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid.
Charles D Wells, Rajesh Gupta, Norbert Hittel, Lawrence J Geiter

Eur Respir J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba™ to background regimens in Germany.
Roland Diel, Norbert Hittel, Tom Schaberg

Respir Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.
Reena L Pande, William R Hiatt, Peter Zhang, Norbert Hittel, Mark A Creager

Vasc Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilostazol treatment of claudication in diabetic patients.
Marc Rendell, Alan T Cariski, Norbert Hittel, Peter Zhang

Curr Med Res Opin· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating peripheral arterial disease in patients with diabetes.
Norbert Hittel, Richard Donnelly

Diabetes Obes Metab· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis